Company intelligence / Profile preview
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Hangzhou, Zhejiang Province (Chekiang Province), Chinabloomberg.com ↗
- Ownership
- Public · 000963
- Employees
- ~12000
- Development stage
- Commercial
01
Overview
The company has multiple approved products and a pipeline of drugs in various stages of development. Their Semaglutide Injection completed Phase I study and is expected to initiate Phase III clinical study. HDM2002 (ELAHERE™), an ADC drug developed with ImmunoGen, received accelerated approval from the FDA in November 2022 for platinum-resistant ovarian cancer.
- Therapeutic areas
- NephrologyEndocrinologyOncologyRare DiseasesNeurologyInfectious Diseases
- Modalities
- Small moleculesBiosimilarsFusion proteinsRecombinant polypeptidesMonoclonal antibodiesADC (Antibody-Drug Conjugates)
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
Request access →03
Partnerships
ImmunoGenHeidelberg PharmaSanyou Biopharmaceuticals
Beyond the preview
Go deeper on Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd..